- Home
- SABS vs MTEX Comparison
SABS vs MTEX Comparison
Compare SABS & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- MTEX
- Stock Information
- Founded
- SABS 2014
- MTEX 1993
- Country
- SABS United States
- MTEX United States
- Employees
- SABS N/A
- MTEX N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- SABS Health Care
- MTEX Health Care
- Exchange
- SABS Nasdaq
- MTEX Nasdaq
- Market Cap
- SABS 19.0M
- MTEX 21.2M
- IPO Year
- SABS N/A
- MTEX 1999
- Fundamental
- Price
- SABS $1.82
- MTEX $11.24
- Analyst Decision
- SABS Strong Buy
- MTEX
- Analyst Count
- SABS 5
- MTEX 0
- Target Price
- SABS $12.40
- MTEX N/A
- AVG Volume (30 Days)
- SABS 246.2K
- MTEX 6.5K
- Earning Date
- SABS 03-28-2025
- MTEX 03-27-2025
- Dividend Yield
- SABS N/A
- MTEX N/A
- EPS Growth
- SABS N/A
- MTEX N/A
- EPS
- SABS N/A
- MTEX N/A
- Revenue
- SABS $1,512,723.00
- MTEX $121,552,000.00
- Revenue This Year
- SABS N/A
- MTEX N/A
- Revenue Next Year
- SABS N/A
- MTEX N/A
- P/E Ratio
- SABS N/A
- MTEX N/A
- Revenue Growth
- SABS N/A
- MTEX N/A
- 52 Week Low
- SABS $1.60
- MTEX $6.75
- 52 Week High
- SABS $6.30
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- SABS 36.28
- MTEX 46.46
- Support Level
- SABS $2.00
- MTEX $10.50
- Resistance Level
- SABS $2.15
- MTEX $11.95
- Average True Range (ATR)
- SABS 0.20
- MTEX 0.66
- MACD
- SABS 0.03
- MTEX 0.00
- Stochastic Oscillator
- SABS 30.99
- MTEX 26.91
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.